Shed light on your success

Our platform has helped dozens of organizations like yours drive your decisions, inform the future,and be ready for what’s next.

We’re making a real impact

150K+

Users

29

Platform

Launches

6

Languages

Worldwide

100%

Goals

Reached

Vital health data that benefits the masses

By combining advanced market research with scientific data from in-market studies, our platform provides direct, ongoing connectivity between healthcare, study or management personnel, product managers, and patients — and in doing so, supports the overall management of health information from clinical trial to commercial launch.

Helping partners follow-up on COVID-19 one year after hospitalization
Studying effectiveness of ALLO as treatment for individuals with early-stage Alzheimer’s disease
Studying autoimmune conditions following check-point inhibition treatment of cancer
Identifying differences in the microbiome in infants may protect or put them at risk
Demonstrating long-term success using the in children with Juvenile Idiopathic Arthritis

Reaching the heart of communities

The RESPOND platform supports community-based clinical research to give diverse underserved and underrepresented communities a voice in clinical research. When the FDA issued their guidance, Enhancing the Diversity of Clinical Trials, recommending broader eligibility and increased enrollment of under-represented populations, our platform had been in use for a number of years by programs at The University of Miami Miller School of Medicine, Buffalo University, and a range of projects with The University of Texas Health Science Center School of Public Health across the state.

Standardizing community-based monitoring of COVID-19 in underserved, underrepresented communities
Identifying better treatments for Hepatitis-C across the state of New York
Revealing high incidents of HPV by tracking vital clinical data within real-time from self-reported
Screening and monitoring lifestyle to delay or prevent the onset of diabetes
Supporting community-based efforts in a city with one of the highest rates of diabetes in the US